Cilostazol
- Product NDC
- 71610-037
- 11-digit product format
- 716100037
- Labeler code
- 71610
- Product ID
- 71610-037_64560280-1d4e-47ff-a839-3a3bef49e760
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cilostazol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA077021
- Marketing category
- ANDA
- Marketing start
- 2004-11-23
- Marketing end
- 0000-00-00
- Substance
- CILOSTAZOL
- Active strength
- 100 mg/1
- Pharmacologic classes
- Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71610-037 | CILOSTAZOL TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | Legacy NDC | 20180222_55ae41fb-6c59-4f41-bdc6-db7f75e98e00.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71610-037-53 | 71610003753 | 60 TABLET in 1 BOTTLE (71610-037-53) | 60 tablet | 2018-02-02 | 0000-00-00 | No | No | Current |
| 71610-037-60 | 71610003760 | 90 TABLET in 1 BOTTLE (71610-037-60) | 90 tablet | 2018-02-02 | 0000-00-00 | No | No | Current |
| 71610-037-80 | 71610003780 | 180 TABLET in 1 BOTTLE (71610-037-80) | 180 tablet | 2018-02-02 | 0000-00-00 | No | No | Current |